State of art and results of the National Registry of Rare Diseases
|
|
- Angel Russell
- 5 years ago
- Views:
Transcription
1 State of art and results of the National Registry of Rare Diseases Manuel Posada* & SpainRDR members *Institute of Rare Diseases Research (IIER) Instituto de Salud Carlos III Spanish Rare Diseases Registries Research Network SpainRDR Madrid, Dec, 11 th -12 th,
2 508,132 + SpainRDR Spanish Rare Diseases Registries Research Network What is this? Qué es ésto? 2
3 Global Repository NHS Rare Diseases Strategy Rare Diseases Information 2. Prevention 3. Health Care 4. Therapies 5. Social care 6. Research 7. Training SpainRDR Spanish Rare Diseases Registries Research Network 3
4 Institute of Rare Diseases Research External Agreements DIRECTOR Manuel Posada Secretary CCAA Congenital Anomalies Depatment Eva Bermejo ASEREMAC Ethic Committee Biobank Manuel Posada Area of Human Genetics Francisco Javier Alonso Area of Epidemiology Ignacio Abaitua CREER CIBERER Registry Ignacio Abaitua Information Unit Cecilia Navascues Outcomes Research Unit Manuel Hens Diagnostic Genetic Department Francisco Javier Alonso Gema Gómez (R. Quality) Translational Research Departments MOLECULAR GENETICS Beatriz Martínez CELLULAR BIOTECHNOLOGY Javier García de Castro THERAPY RESEARCH Sonsoles Hortelano RARE TUMOR IN CHILDREN Francisco Javier Alonso Rare Bone Diseases Antonio Morales RARE DISEASES EPIDEMIOLOGY Verónica Alonso TOXIC OIL SYNDROME Ignacio Abaitua AUTISM SPECTRUM DISORDERS Manuel Posada Medical Societies ASEBIO AELMHU FUNDACIÓN FEDER Research Networks ENERCA RIBERMOV GIR SALAMANCA University SpainRDR Spanish Rare Diseases Registries Research Network Participants Coordinator: Institute of Rare Diseases Research (IIER, ISCIII) Manuel Posada de la Paz Spanish Ministry of Health, Social Services and Equity Autonomous Communities and Cities - Health Departments (17 Spanish regions) Medical societies (SEAIC; SEEP; SENP; SEPAR; SEMFYC; SEN; AEGH; AETAPI; FEAPS) CIBERER (some teams) Research Networks Industry (AELMHU, ASEBIO) Patient organizations (FEDER) Foundations (FEDER) HARMONIZATION 4
5 SpainRDR: Main Aim To set up a National Rare Disease Registry using the interaction between two different methodological approaches Population-based registries Patient registries outcomes research The basic aim is to improve prevention, diagnosis, prognosis (at different levels), treatment and quality of life for RD patients and their families using high quality information provided by the RD registry To provide the necessary information to the NHS To facilitate the implementation of RD-oriented health and social policies To promote the translational research SpainRDR Spanish Rare Diseases Registries Research Network 5
6 Types of registries Populationbased Surveillance Planning Etiology Patients Participation Autonomy Access Empowerment Patients registry Therapeutic Bioamrkers Outcomes SpainRDR Spanish Rare Diseases Registries Research Network 6
7 General scheme for patient registered by themselves PEOPLE APPLICATION FORM Institute of Rare Diseases Research IIER, ISCIII APPROVED RESEARCHERS REQUEST PATIENT REGISTRIES DATA ENTRY HEALTH REGIONS INFOREMD CONSENT CLINICAL REPORT B.D. DISEASE REGISTRY QUESTIONNAIRES BIOBANK RD MANAGER B.D. B.D. B.D. What has been done? Qué se ha desarrollado? 7
8 Number of CCAA with legislation Castilla y León Pais Vasco 14 Navarra Number of Regions with Legislation Canarias La Rioja Ceuta y Melilla y Asturias Cataluña Aragón Baleares Cantabria Comunidad Valenciana 4 Castilla la Mancha Modifed Jan Andalucía Modified June 2 Murcia Extremadura 0 Month - Year 8
9 SOPs and Data Validity processes CA PNTs Data entry: Data structure User s manual Procedures manual Data sources: Source analysis Data integration and management procedures Consolidation of the database Security document Generation of the AC exchange file Importation of AC files IIER PNTs Generation of AC errors and queries file External data sources Data process and management Correction of errors and queries response AC registry updating Security document MDS & CDE 9
10 Population-based registry ICD-O ERA- EDTA ICD9- CM ICD10- BPA MINIMUM DATASET ICD10 Is RD well identified? YES Disease name DICE-APER Primary Care SNOMED CT Orpha codes OMIM Tareas WP3 Estandarization de los análisis estadísticos 10
11 Enfermedad Renal Quística Informe para los Años 2010 a 2012 España GeoTMap 11
12 Delphi Study: What kind of RD Registries must be promoted by the Official Governamental Bodies Prevalence > 0.1/10,000 Orphan drugs and orphan designation Rare Metabolic and rare neurological diseases Improvement of the quality of life Training on-line SpainRDR Spanish Rare Diseases Registries Research Network 12
13 What type of results? Qué clases de resultados? Contribución de las CCAA Estudio Piloto Datos reales
14 PILOT STUDY CASES BY ICD GROUPS (n= 818,348) Actual Study ,046,394 Cases declared 93.8% of población 14
15 Data checking? Revisando datos? Autonomous Communities Cases Population - INE % Total Casese 100,000 inhab Comunidad Autónoma de Andalucía , ,99 Comunidad Autónoma de Aragón , ,57 Principado de Asturias , ,24 Comunidad Autónoma de Illes Balears , ,80 Comunidad Autónoma de Canarias , ,64 Comunidad Autónoma de Cantabria , ,38 Comunidad Autónoma de Castilla-La Mancha 4, ,46 Comunidad Autónoma de Castilla y León , ,27 Comunidad Autónoma de Cataluña , ,96 Comunidad Autónoma de Extremadura , ,98 Comunidad Autónoma de Galicia , ,00 Comunidad de Madrid , ,57 Región de Murcia , ,24 Comunidad Foral de Navarra , ,46 Comunidad Autónoma de País Vasco , ,08 Comunidad Autónoma de La Rioja , ,94 Comunidad Valenciana , ,65 Ciudad Autónoma de Ceuta , ,00 Ciudad Autónoma de Melilla , ,00 15
16 Sources of information FUENTES/Sources N % C CMBD ,86 D anomalías congénitas ,25 H medicamentos huérfanos ,15 M mortalidad ,83 N metabolopatías (Cribado neonatal) 823 0,10 O Otros 331 0,04 P Historia clínica electrónica. Atención Primaria ,34 Q Historia clínica electrónica de hospitales ,31 R Registro de enfermedades renales crónicas ,01 S Registros específicos de ER de cada CA ,14 T Registro de tumores ,50 A-Registro Asociaciones de pacientes E- Registro de enfer. declaración obligatoria G- Registro de instituciones sociales y educativas I- Registros de investigación 16
17 Data information Información Rare Diseases: Some preliminary data Number of cases ICD Groups 17
18 Mental Disorders Distribution by age - Sex and group of diseases Renal & Genital Congenital Malformations Cardiovascular diseases RD by diseases type ER según tipo de enfermedad Distribution Number of cases
19 RD and number of cases (examples) Certain infectious and parasitic diseases BEHCET SYNDROME 1338 SARCOIDOSIS 5233 Neoplasms POLYCYTHEMIA VERA 3118 MYCOSIS FUNGOIDES 1856 Endocrine, metabolic and inmune diseases CHRONIC LYMPHOCYTIC THYROIDITIS 8003 CUSHING S SYNDROME 3579 HYPOPARATHYROIDISM 3473 ACROMEGALY AND GIGANTISM 1002 ALPHA-1-ANTIRYTRIPSIN DEFICIENCY 811 CYSTIC FIBROSIS 2598 FATTY ACID OXIDATION DISORDERS 233 Nervous system DEMENTIA WITH LEWI BODIES 8494 AMYOTROPHIC LATERAL SCLEROSIS 3558 HUNTINGTON S DISEASE 965 MYASTHENIA GRAVIS 5918 Respiratory system IDIOPATHIC PULMONARY FIBROSIS 4937 ANTRACOSILICOSIS 2252 ASBESTOSIS 1734 PULMONARY ALVEOLAR MICROLITHIASIS 28 Blood and blood-forming organs IDIOPATHIC TROMBOCYTOPENIC PURPURA 7636 HEMOPHILIA A 2099 Digestive system GIANT CELL ARTERITIS 6638 WEGENER S GRANULOMATOSIS 1396 POLYARTERITIS NODOSA 1090 Skin and subcutaneous tissue PEMPHIGUS 1445 Musculoskeletal System and Connective Tissue SJOGREN S DISEASE 7865 DISSEMINATED LUPUS ERIYTHEMATOSUS GENERALIZED SCLERODERMA 4716 DERMATOMYOSITIS 1564 POLYMYOSITIS 819 Congenital Anomalies SPINA BÍFIDA 4862 ICHTHYOSIS CONGENITA 798 OSTEOGENESIS IMPERFECTA 551 MARFAN S SYNDROME 792 CONDRODISTROFIA CONGENITA 696 CONGENITAL HIATAL HERNIA 306 PRADER-WILLI SYNDROME 297 X-FRAGILE SYNDROME 368 EHLERS-DANLOS SYNDROME
20 Patient Registries in SpainRDR Registros de Pacientes en SpainRDR 20
21 Medical Societies Spanish Society of Allergy and Clinical Immunology (SEAIC) Spanish Society of Pneumology and Thoracic Surgery (SEPAR) Spanish Society of Family and Community Medicine (SEMFYC) Spanish Society of Pediatric Pneumology (SENP) Spanish Society of Neurology (SEN) Spanish Society of Pediatric Endocrinology (SEEP) Spanish Association of ASD Professionals (AETAPI) Spanish Confederation of Organizations for people with intellectual disability (FEAPS) Spanish Association of Human Genetic (AEGH) Wolfram Syndrome Research and Assistance Spanish Association (AEIASW) Research Networks Iberoamerican multidisciplinary network for the movement disorders study: Parkinson s Disease and Spinocerebellar Ataxias (RIBERMOV). European Reference Network for Rare and Congenital Anemias (ENERCA) Head of Regenerative Medicine Unit, CIEMAT Spanish Rare Cancer Network - REDECAN 21
22 SEEP Differentiation Sexual Disorders (DSD) & Congenital Suprarenal Hyperplasia SEAIC Bradikinin mediated angoiaedema SEPAR Alveolar proteinosis; Alpha-1 antitrypsin deficiency; Histiocytosis X; Lymphangiomatosis; Sarcoidosis & Tracheal stenosis SENP Pulmonar Interstitial Fibrosis in children Patients Registries SEN Spinocerebellar ataxias and Paraparesia Spastic Familiar CIEMAT Epidermolysis Bullosa ENERCA Congenital and rare aenemias Spanish Clinical Group of the Wolfram Syndrome Wolfram Syndrome Cystinosis Research Team Cystinosis Final Messages Mensajes finales 22
23 Other Related International Actions SpainRDR Spanish Rare Diseases Registries Research Network Translational Research National RD Strategy Projects TREAT-NMD Clinical Trial School and RD children (bullying) Drugs repurposing Ictiosis mrna and autoimmune diseases 23
24 Next Steps To consolídate the Population-based registry - Regions Legal Framework First results Going-on with the promotion of patient registries Validity Audit Quality Assurance Plan Dissemination Websites Papers Align with other related projects RD-CONNECT European RD Platform (Ispra, Italia) Ontologies and GUID Summary SpainRDR is covering an important role in the RD field in Spain Full Cooperation (NHS & SS; Researchers; Industry and Patient Organizations - FEDER) Challeging topcis ELSI Case ascertainment Validity and reliability data Sostenibility A national experiency useful for some others 24
25 Acknowledgements CCAA: Zurriaga O, Astray J, Aldana-Espinal JM, Margolles MJ, Jiménez J, Palomar JA, Santana M, Carrillo P, Ramalle-Gomarra E, Ramos JM, Galán E, Arribas FE, Álamo R, Gutiérrez-Ávila G, Galmés A, García-Ribes M, Navarro C, Teijeira S, Errezola M, Ardanaz ME, García T IIER: Alonso V, Bermejo E, Morales A and Abaitua I SpainRDR Members Network 25
26 Razonar y convencer, qué difícil, largo y trabajoso! Sugestionar? Qué fácil, rápido y barato! to argue and convince, such difficult, time-consuming and hard work! to influence? How quick, easy and inexpensive! Santiago Ramón y Cajal ( ) Médico español. Thank you Institute of Rare Diseases Research (IIER) Instituto de Salud Carlos III Manuel Posada mposada@isciii.es 26
Consumer Price Index (CPI). Base 2006 October Monthly change Change over last December
12 November 2010 Consumer Price Index (CPI). Base 2006 October 2010 Overall index Monthly change Change over last Annual change October 0.9 1.8 2.3 Main results The annual change of the CPI for the of
More information28.8% of deaths were due to diseases of the circulatory system and 26.7% to tumours
19 December 2018 Deaths according to cause of death Year 2017 28.8% of deaths were due to diseases of the circulatory system and 26.7% to tumours Diseases of the respiratory system increased by 10.3% and
More informationConsumer Price Index (CPI). Base 2011 May Monthly change Change over last May Annual change May
12 June 2013 Consumer Price Index (CPI). Base 2011 May 2013 all index Monthly change Change over last May Annual change May 0.2 0.2 1.7 Main results The annual change of the CPI for the month of May stands
More informationNATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT.
D. Taruscio and L. Vittozzi National Centre for Rare Diseases National Institute of Health Rome, Italy NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT. ICORD 2014, Ede
More informationHospital indicators by Regional Communities, (Longitudinal analysis of morbidity indicators and hospital staffing in mental health)
Originals A. Mede Herrero 1 A. Sarria Santamera 1,2 Hospital indicators by Regional Communities, 1980-2004 (Longitudinal analysis of morbidity indicators and hospital staffing in mental health) 1 Agencia
More informationANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
SECRETARÍA GENERAL DE SANIDAD DIRECCIÓN GENERAL DE SALUD PÚBLICA Y SANIDAD EXTERIOR ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
More informationSocial inequality in morbidity, framed within the current economic crisis in Spain
Zapata Moya et al. International Journal for Equity in Health (2015) 14:131 DOI 10.1186/s12939-015-0217-4 RESEARCH Social inequality in morbidity, framed within the current economic crisis in Spain A.R.
More informationLong-term trends in pancreatic cancer mortality in Spain ( )
Seoane-Mato et al. BMC Cancer (2018) 18:625 https://doi.org/10.1186/s12885-018-4494-3 RESEARCH ARTICLE Open Access Long-term trends in pancreatic cancer mortality in Spain (1952 2012) Daniel Seoane-Mato
More informationRare Disease Day Brussels, 1 March
Research activities in Europe: Trends and determinants Rare Disease Day Brussels, 1 March 2010 Research Death valley Development Collaboration clinicians / researchers Pharmaceutical Innovation / Performance
More informationTreatments that require prior authorization by NHS
Treatments that require prior authorization by NHS If you want to apply for the cost reimbursement covering your treatment in Poland please check if you need to apply before your medical travel. Please
More informationPOPULATION BIOBANKS INTEGRATED IN THE SPANISH NATIONAL BIOBANK NETWORK
Roma, 9/03/2012 POPULATION BIOBANKS INTEGRATED IN THE SPANISH NATIONAL BIOBANK NETWORK BBMRI.es Manuel M Morente Spanish National Biobank Network ISCIII Population Biobanks integrated In the Spanish National
More informationUSEFULNESS OF ONTOLOGIES FOR RARE DISEASES
USEFULNESS OF ONTOLOGIES FOR RARE DISEASES M a n u e l P o s a d a, Ve r ó n i c a A l o n s o a n d E s t r e l l a L ó p e z M a r t í n I n s t i t u t e o f R a r e D i s e a s e s R e s e a r c h
More informationPlanning and health programmes
Planning and Health plans are the principal instrument used by the authorities to guide and direct their resources towards previously defined objectives of. They embrace the main objectives of the corresponding
More informationRafael Poveda, Yolanda Jiménez, Carmen Gavaldá, José María Sanchís, Enrique Carbonell, María Margaix, Gracia Sarrión
Pediatric dental care in a tertiary public hospital. Four years of experience in the Service of Stomatology of Valencia University General Hospital (Valencia, Spain) Rafael Poveda, Yolanda Jiménez, Carmen
More informationVaccination against bluetongue in Spain
Vaccination against bluetongue in Spain June 2014 Blue Tongue (BT) was first detected in Spain among 1956 and 1960, when BT virus (BTV) serotype 10 was detected on the south west of the territory. Once
More informationSupervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles
I Congreso de GESIDA Madrid, 21-24 de Octubre del 2009. Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles José M. Miró, 1 Miguel Montejo,
More informationMeeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission
Meeting with EMA: cooperation in the field of ERNs Enrique Terol DG SANTE European Commission London 16 May 2017 The road to European Reference Networks (ERNs) Imagine if the best specialists from across
More informationInternal Medicine End of Rotation
Internal Medicine End of Rotation EXAM TOPIC LIST CARDIOVASCULAR Angina pectoris Cardiac arrhythmias/conduction disorders Cardiomyopathy Congestive heart failure Coronary vascular disease Endocarditis
More informationPrevalence of HCV-HIV coinfection. newborn babies
Prevalence of HCV-HIV coinfection among mothers of newborn babies Mercedes Díez Secretariat of the National Plan on AIDS National Center of Epidemilogy Madrid, 24 November 26 Overview Background HIV epidemic
More informationGranada (Spain), Noviembre 7th, 2012
II ESBB Annual Conference Granada (Spain), Noviembre 7th, 2012 II ESBB Annual Conference III Spanish Biobank Congress Granada (Spain) November 6 th 11th 2012 Manuel M Morente Red Nacional de Biobancos
More informationPHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe
www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org
More informationEXAMPLE OF A SUCCESSFUL R&D COLLABORATION: THE RIBERMOV LATIN-AMERICAN NETWORK ON MOVEMENT DISORDERS.
EXAMPLE OF A SUCCESSFUL R&D COLLABORATION: THE RIBERMOV LATIN-AMERICAN NETWORK ON MOVEMENT DISORDERS. Antoni Matilla Dueñas Director Functional and Translational Neurogenetics Unit RIBERMOV Coordinator
More informationReference values of the Strengths and Difficulties Questionnaire (SDQ) version for parents in the Spanish population, 2006
Original Laura M. Barriuso-Lapresa 1 Lauro Hernando-Arizaleta 1 Luis Rajmil 2,3 Reference values of the Strengths and Difficulties Questionnaire (SDQ) version for parents in the Spanish population, 2006
More information163 online convention feedback forms were submitted from the total of 500+ conference participants.
TESOL SPAIN 40th Annual Convention. Convention Feedback Elche, 2017. Dear TESOL-SPAIN Members, This year we had a large number of participants attending an event held outside Madrid at our 40th TESOL-SPAIN
More informationStaging of Type 1 Diabetes: Clinical Implications. April Deborah Hefty, MN, RN, CDE.
Staging of Type 1 Diabetes: TT Clinical Implications April 2016 Deborah Hefty, MN, RN, CDE dhefty@benaroyaresearch.org BRI s major contributions to type 1 diabetes research Identified type 1 diabetes susceptibility
More informationSUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES. Domenica Taruscio
Presentation to the European Conference Rare Diseases Luxembourg, 21-22 June, 2005 SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES Domenica Taruscio taruscio@iss.it http://www.cnmr.iss.it Co-ordinator
More informationMeasuring Long-Term Conditions in Scotland - A summary report
Measuring Long-Term Conditions in Scotland - A summary report Introduction This summary report provides insight into: What are the most common long-term conditions in Scotland? What is the population prevalence
More informationCUMULATIVE ILLNESS RATING SCALE (CIRS)
CUMULATIVE ILLNESS RATING SCALE (CIRS) The CIRS used in this protocol is designed to provide an assessment of recurrent or ongoing chronic comorbid conditions, classified by 14 organ systems. Using the
More informationNormative values of EQ-5D-5L for diabetes patients from Spain
Nutr Hosp. 2015;32(4):1595-1602 ISSN 0212-1611 CODEN NUHOEQ S.V.R. 318 Original / Síndrome metabólico Normative values of EQ-5D-5L for diabetes patients from Spain Daniel Collado Mateo 1, Miguel A. García
More information2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.
Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis
More informationState of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report
State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Belgium Report The definition of rare diseases in the Belgian Plan for Rare Diseases
More informationAmbulation in patients with myelomeningocele: a study of 1500 patients
Paraplegia 31 (1993) 28-32 1993 International Medical Society of Paraplegia Ambulation in patients with myelomeningocele: a study of 1500 patients I Dfaz Llopis MD, M Bea Munoz MD, E Martinez Agullo MD,
More informationGastrointestinal Oncology
2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission
More informationHI-1051: Certified Professional Coder Preparation Course
Course Code/Title: HI-1051: Certified Professional Coder Preparation Course Course Hours: 320 Duration (wks): 16 weeks Chapter 1 The Business of Medicine Coding as a Profession The Difference between Hospital
More informationJornada sobre INVESTIGACIÓN CLÍNICA EN PEDIATRÍA. Cristina Calvo Hospital Universitario La Paz
Jornada sobre INVESTIGACIÓN CLÍNICA EN PEDIATRÍA Cristina Calvo Hospital Universitario La Paz INDEX 1. Research structure 1. Clinical Trials Unit 2. Pediatric Research Groups 2. Research Networks 3 RESEARCH
More informationAllied and Therapeutic Extender Benefit
Allied and Therapeutic Extender Benefit 2012 Allied and Therapeutic Extender Benefit The Allied and Therapeutic Extender Benefit is available on the Executive and Comprehensive Plans only. Overview This
More informationSpotlight on...newborn screening for rare diseases in Spain
Spotlight on...newborn screening for rare diseases in Spain Evolving technology for newborn screening challenges existing programmes and policies The advent of now technologies such as electrospray ionization
More informationICD10 revision process and rare diseases. Ségolène Aymé WHO Topic Advisory Group on Rare Diseases
ICD10 revision process and rare diseases Ségolène Aymé WHO Topic Advisory Group on Rare Diseases ICD Revisions 30 26 Interval (years) 25 20 15 10 7 9 10 10 9 10 7 10 10 14 5 0 ICD-1 ICD-2 ICD-3 ICD-4 ICD-5
More informationTime trends in socio-economic inequalities in the lack of access to dental services among children in Spain
Pinilla et al. International Journal for Equity in Health (2015) 14:9 DOI 10.1186/s12939-015-0132-8 RESEARCH Open Access Time trends in socio-economic inequalities in the lack of access to dental services
More information5.2 Main causes of death Brighton & Hove JSNA 2013
Why is this issue important? We need to know how many people are born and die each year and the main causes of their deaths in order to have well-functioning health s. 1 Key outcomes Mortality rate from
More informationNO PUBLIC HEALTH STRATEGY IN ASD IN EUROPE CALL FOR TENDERS. Antoni Monserrat Directorate of Public Health
NO PUBLIC HEALTH STRATEGY IN ASD IN EUROPE CALL FOR TENDERS Antoni Monserrat Directorate of Public Health 1.Prevalence / Health and economic burden 2. Early detection, diagnosis early intervention and
More informationBOTLHE MEDICAL AID SCHEME - APPLICATION FORM
What you must do 1. 2. 3. 4. 5. Once you have submitted your application form, here is what will happen: - If any details are missing or if we need more information for underwriting purposes, we will contact
More informationThe EU rare diseases policy framework: the context for ERNs
The EU rare diseases policy framework: the context for ERNs Jaroslaw Waligora DG Health and Food Safety, European Commission Unit C.1, Programme Management and Diseases Report from an expert group of the
More informationENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
More informationLessons from the Development of a Canadian National System of Surveillance
Lessons from the Development of a Canadian National System of Surveillance NATHALIE JETTÉ MD, MSc, FRCPC Assistant Professor Neurology Hotchkiss Brain Institute Calgary Institute of Population and Public
More informationCITY OF BEVERLY HILLS. Office of Emergency Management MEMORANDUM
CITY OF BEVERLY HILLS Office of Emergency Management MEMORANDUM TO: FROM: Health and Safety Commission Pamela Mottice Muller, Director DATE: July 25, 2016 SUBJECT: Health and Safety Observances Commemorative
More informationWelcome. BORJA FANJUL Managing Director for Disability of Ministry of Health, Social Services and Equality
Welcome BORJA FANJUL Managing Director for Disability of Ministry of Health, Social Services and Equality ZSUZSANNA SZILVASY President of Autism-Europe MIGUEL ÁNGEL DE CASAS President of Autism-Spain Presentation
More informationEffectiveness of the 2010/11 seasonal trivalent influenza. vaccine in Spain: preliminary results of a case control study.
Rapid communications Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case control study C Savulescu (csavulescu@isciii.es) 1,2, S Jiménez-Jorge 1,3,
More informationRayos Prior Authorization Program Summary
Rayos Prior Authorization Program Summary FDA APPROVED INDICATIONS AND DOSAGE FDA-Approved Indications: 1 Agent Indication Dosage Rayos (prednisone delayedrelease tablet) as an anti-inflammatory or immunosuppressive
More informationESPECIAL. M. Greenacre Department of Economics and Business. Centre for Research in Health Economics (CRES). Universitat Pompeu Fabra. Barcelona.
ESPECIAL Correspondence analysis of the Spanish National Health Survey M. Greenacre Department of Economics and Business. Centre for Research in Health Economics (CRES). Universitat Pompeu Fabra. Barcelona.
More informationFAQ Identifying and enrolling participants
FAQ Identifying and enrolling participants WHO IS ELIGIBLE - CASES? Patients with a new diagnosis of primary systemic vasculitis Patients suitable as cases are over 18 years with a new presentation or
More informationPremium Specialty: Pediatrics
Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium
More informationLINEARIZATION RULES FOR ORPHANET CLASSIFICATIONS
September 2014 LINEARIZATION RULES FOR ORPHANET CLASSIFICATIONS Procedural document www.orpha.net Table of contents Table of contents... 2 Introduction... 3 I. Purpose... 3 II. Disclaimer... 3 III. Range
More informationCHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER
CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER The Prescribed Minimum Benefit Chronic Disease List In terms of the Medical Scheme Act Regulations that came into effect on 1 January 2004, Medical
More information(CIBERESP) Instituto Max Weber
The social costs of chronic pain in Spain Renata Villoro. Instituto Max Weber Julio López Bastida. Servicio de Evaluación. Servicio Canario de Salud.. CIBER Epidemiología y Salud Publica (CIBERESP) Juan
More informationFinancial Report. Moving Together
Financial Report 2013 Moving Together Our Purpose To improve the quality of life of people who have, or are at risk of developing musculoskeletal conditions. Our Values Respect and integrity Service and
More informationASDEU Final Conference. Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain. 29th-30th January 2018
ASDEU Final Conference Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain Monday 29th January 29th-30th January 2018 8.30 am - Registrations 9.00-9.10: Welcome
More informationThe 2015 Barcelona Congenital Hyperinsulinism Family Conference
The 2015 Barcelona Congenital Hyperinsulinism Family Conference Dra. Paula Casano Sancho Pediatric Endocrinologist Sant Joan de Deu Hospital- U.Barcelona Congenital Hyperinsulinism: Spanish prespective
More informationCLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES
CLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES Subanalysis Spanish Registry on Heart TransplantaCon (1984 2010) Authors: Dimpna C. Albert 1 María J. Paniagua
More informationContents. copyrighted material by PRO-ED, Inc. Chapter 1. Chapter 2. Chapter 3. Chapter 4. Chapter 5. Conditions in Athletic Injuries
Acknowledgments xiii Introduction to the First Edition xv Introduction to the Second Edition xvii Chapter 1 Conditions in Athletic Injuries Anterior Cruciate Ligament (ACL) Tear 2 Biceps Tendon Strain
More informationUpdate on EEA s near real time air quality data exchange
Update on EEA s near real time air quality data exchange Jaume Targa (EEA ETC/ACC) Acknowledgement Thanks to all nrt data providers Currently there are 71 providers Latvian Environment, Geology and Name
More informationSocial justice: A qualitative and quantitative study of representations of social justice in children of primary education
Social justice: A qualitative and quantitative study of representations of social justice in children of primary education Almudena Juanes García 1, Vanesa Sainz López 1, Tatiana García Vélez 1 and Antonio
More informationDevelopment of ISO archetypes for the standardisation of data registration in the Primary Care environment
Digital Healthcare Empowering Europeans R. Cornet et al. (Eds.) 2015 European Federation for Medical Informatics (EFMI). This article is published online with Open Access by IOS Press and distributed under
More informationNew evidences of the effects of the Mediterranean diet in the prevention of cardiovascular disease
THE PREDIMED STUDY New evidences of the effects of the Mediterranean diet in the prevention of cardiovascular disease Dr. María Isabel Covas Cardiovascular Risk and Nutrition Research Group The REGICOR
More informationLIST OF CLINICAL PRIVILEGES DIETITIAN
LIST OF CLINICAL PRIVILEGES DIETITIAN AUTHORITY: Title 10, U.S.C. Chapter 55, Sections 1094 and 1102. PRINCIPAL PURPOSE: To define the scope and limits of practice for individual providers. Privileges
More informationAn EU Strategy for Autism to leave No One Behind Introduction to the ASDEU programme and preliminary results of studies into prevalence and cost
An EU Strategy for Autism to leave No One Behind Introduction to the ASDEU programme and preliminary results of studies into prevalence and cost Manuel Posada on behalf the ASDEU network European Parliament
More informationImmunology 2011 Lecture 20 Autoimmunity 18 October
Immunology 2011 Lecture 20 Autoimmunity 18 October APC Antigen processing (dendritic cells, MΦ et al.) Antigen "presentation" Ag/Ab complexes Antigenspecific triggering B T ANTIGEN Proliferation Differentiation
More informationBAROPENINGHOURS, ALCOHOLCONSUMPTIONANDWORKPLACEACCIDENTS
BAROPENINGHOURS, ALCOHOLCONSUMPTIONANDWORKPLACEACCIDENTS NICOLAUMARTÍNBASSOLS JUDITVALLCASTELLÓ July2017 CRES-UPFWorkingPaper#201707-97 BAR OPENING HOURS, ALCOHOL CONSUMPTION AND WORKPLACE ACCIDENTS NICOLAU
More informationGlobal Healthcare Panel Book 2017
Global Healthcare Panel Book 2017 www.philomathresearch.com About Philomath Research Philomath Market Research is a global healthcare fieldwork and data collection service provider for market research
More informationFDA s Patient-Focused Drug Development Initiative
FDA s Patient-Focused Drug Development Initiative Theresa M Mullin, PhD Director, Office of Planning and Informatics FDA Center for Drug Evaluation and Research April 24, 2013 Drug Benefit-Risk Assessment
More informationSpain Carme Pinyol Natividad Calvente Pedro Gómez Cristina Espinosa Carlos Martín Paloma González Ana Becerro de Bengoa José Vicente Galindo
Chapter name President President-Elect Past President Secretary Treasurer Director Director Director Other, non-board positions (please list if applicable) When are elections held for the Chapter Board?
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Definition of a Rare Disease Hungary Report Hungary has adopted the European Commission definition of a rare
More informationSustainability Report
2017 Sustainability Report We have a great future that we are building today for the next generation of pharmacists. Professionalism, innovation and sustainability are the principles on which we base this
More informationKeeping Care Complete Fact Sheet: International Findings
Keeping Care Complete Fact Sheet: International Findings Keeping Care Complete is the first international survey to shed light on experiences and insights of family caregivers of individuals with bipolar
More informationI-Brite - Ocular/Medical/General Information
I-Brite - Ocular/Medical/General Information Na me Date Gender (First) (Middle) (Last) Date of Birth Age Occupation Phone No. Address City State Zip Please describe what is abnormal about the appearance
More information9th Annual ESPAnet Conference Sustainability and transformation in European Social Policy
9th Annual ESPAnet Conference Sustainability and transformation in European Social Policy Valencia, 8-10 September 2011 Stream 13: Social and health care Stream convenors: Mª Carmen Alemán (UNED) and Francisco
More information21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS
IV CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS IV INTERNATIONAL ON RESEARCH AND INNOVATION IN IVNEURODEGENERATIVE DISEASES IV CONGRESS ALICANTE 2016 Septiembre
More informationChronic Illness Benefit Application form 2018
Chronic Illness Benefit Application form 2018 Contact us Tel (Members): 0860 99 88 77, Tel (Health partners): 0860 44 55 66, PO Box 784262, Sandton, 2146, www.discovery.co.za. Who we are Discovery Health
More informationGastrointestinal Oncology
1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era ra o f Pe Perss on onal aliz ized ed M edicine PRELIMINARY PROGRAM Madrid, 29 November -
More informationGrupo de Trabajo de Desfibrilador Implantable, Sección de Electrofisiología y Arritmias, Sociedad Española de Cardiología, Madrid, Spain
SPECIAL ARTICLE Spanish Implantable Cardioverter-Defibrillator Registry. 5 th Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (28) Rafael Peinado,
More informationEMERGENCY PREPAREDNESS AND RESPONSE
EMERGENCY PREPAREDNESS AND RESPONSE Prepared to Respond MESSAGE FROM THE DIRECTOR GENERAL Effective national and global response capabilities are essential to minimize the impacts from nuclear and radiological
More information0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia
Certain infectious and parasitic diseases 0101 Intestinal infectious diseases 0102 Tuberculosis 0103 Infections with a predominantly sexual mode of transmission 0104 Viral infections characterized by skin
More informationCHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER
CHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER Prescribed Minimum Benefits The prescribed minimum benefits (PMBs) comprise a list of 270 conditions or group of conditions
More informationEpidemiology and classification of smoking related interstitial lung diseases
Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: McCoy MS, Carniol M, Chockley K, Urwin JW, Emanuel EJ, Schmidt
More informationSystem and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program
System and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program Irina Logvina Center for Drug Evaluation and Research, Ukrainian MH Antalya, Turkey December 10-13, 2013 Ukraine
More informationVictimology. Code: ECTS Credits: 6. Degree Type Year Semester
2017/2018 Victimology Code: 100436 ECTS Credits: 6 Degree Type Year Semester 2500257 Criminology OB 2 2 Contact Name: Manuel Casado Gomez Email: Manuel.Casado@uab.cat Other comments on languages Use of
More informationInternational Classification of Diseases in the field of rare diseases Revision process. Ségolène Aymé Chair of the Topic Advisory Group At WHO
International Classification of Diseases in the field of rare diseases Revision process Ségolène Aymé Chair of the Topic Advisory Group At WHO ICD Revisions 139 161 179 189 205 214 200 954 965 1,040 1,164
More informationPlease fill in all the blanks or check the appropriate boxes, the starred fields (*) are optional:
Alopecia Areata Registry: Short Form Questionnaire: Date of Revision: June 2010 Page 1 of 5 This questionnaire is only for people who live in the U.S.A and who have personal or family documentation of
More informationMedical Mental Health Reference Data. Florida Safe Families Network FSFN. May 12, 2017 Page 1 FSFN. Medical Mental Health. Page: Tab Name: Field Name:
Mental Health Profile Alcohol, Drugs, Marijuana, Solvents Frequency Daily Isolated Known Use / Unknown Frequency Occasional/Monthly Use Weekly Medical History Condition Type Dental Medical Mental Medical
More information5/22/2013. Alan Zuckerman 1, Swapna Abhyankar 1, Tiffany Colarusso 2, Richard Olney 2, Kristin Burns 3, Marci Sontag 4
Alan Zuckerman 1, Swapna Abhyankar 1, Tiffany Colarusso 2, Richard Olney 2, Kristin Burns 3, Marci Sontag 4 1 National Library of Medicine, NIH, Bethesda, MD, USA, 2 Centers for Disease Control and Prevention,
More informationUniversity of Bristol - Explore Bristol Research
Hunt, L., Ben-Shlomo, Y., Whitehouse, M., Porter, M., & Blom, A. (2017). The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following
More informationEmergency Preparedness and Response
Emergency Preparedness and Response Prepared to Respond MESSAGE FROM THE DIRECTOR GENERAL Effective national and global response capabilities are essential to minimize the impacts from nuclear and radiological
More informationEUROPASS DIPLOMA SUPPLEMENT
EUROPASS DIPLOMA SUPPLEMENT TITLE OF THE DIPLOMA (ES) Técnico Superior en Imagen para el Diagnóstico y Medicina Nuclear TRANSLATED TITLE OF THE DIPLOMA (EN) (1) Higher Technician in Diagnostic Imaging
More informationNational Dementia Intelligence Network briefing
Reasons why people with dementia are admitted to a general hospital in an emergency National Dementia Intelligence Network briefing Introduction In recent years there have been a number of national reports
More informationPREMATURITY/ESTIMATED GESTATIONAL AGE
PREMATURITY/ESTIMATED GESTATIONAL AGE 765.21 < 24 completed weeks of gestation P07.21 Extreme immaturity of newborn, gestational age less than 23 completed weeks P07.22 Extreme immaturity of newborn, gestational
More informationFirst Interim Report to the European Commission DG-SANCO for: Grant Agreement No.: (790655) EAIS. December Annex 2
First Interim Report to the European Commission DG-SANCO for: Grant Agreement.:2005112 (790655) EAIS. December 2006 Annex 2 European Autism Information System (EAIS) Project: Design of a Prevalence study.
More informationPaolo G. Casali Annalisa Trama
Paolo G. Casali Annalisa Trama Objectives With regard to RCs in the EU, to improve: 1. Epidemiological surveillance 2. Quality of care through ERNs 3. Clinical practice guidelines 4. Innovation 5. Medical
More informationTable of Contents. Preface... xi. Part I: Introduction to Movement Disorders
Table of Contents Visit www.healthreferenceseries.com to view A Contents Guide to the Health Reference Series, a listing of more than 14,000 topics and the volumes in which they are covered. Preface...
More information